Loading…
Editorial commentary: Use of cerebral embolic protection devices during transcatheter aortic valve replacement
Future studies should be designed with a larger sample size and adequate power, proper patient selection for the use of embolic protection devices such as patients with heavily calcified valves and/or patients with advanced atherosclerosis of aortic root and arch rather than selecting all TAVI patie...
Saved in:
Published in: | Trends in cardiovascular medicine 2018-08, Vol.28 (6), p.419-420 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Future studies should be designed with a larger sample size and adequate power, proper patient selection for the use of embolic protection devices such as patients with heavily calcified valves and/or patients with advanced atherosclerosis of aortic root and arch rather than selecting all TAVI patients. [...]we need to ask ourselves should every patient that undergoes TAVI need these devices? The current evidence is hypothesis generating rather than providing solid evidence in efficacy and surely need further randomized trials with a larger sample size in this regard. |
---|---|
ISSN: | 1050-1738 1873-2615 |
DOI: | 10.1016/j.tcm.2018.02.001 |